A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor.

Area of Science:

• Immunology
• Structural Biology
• Biochemistry

Background:

• Interleukin 4 (IL-4) and IL-13 are key cytokines in allergic hypersensitivity and asthma.
• Both cytokines share receptor components (IL-4Ralpha and IL-13Ralpha1), explaining overlapping functions.
• Understanding their binding mechanism is vital for developing targeted allergy and asthma therapies.

Purpose of the Study:

• To analyze the structure-function relationship of the IL-4 and IL-13 interaction with their receptor subunit IL-4Ralpha.
• To elucidate how molecular recognition by receptor subunits contributes to binding affinity and specificity.
• To inform the design of IL-4 or IL-13 specific drugs.

Main Methods:

• Structure/function analysis of IL-4 variants.
• In vitro binding studies.
• Mutagenesis studies to probe protein-protein interactions.

Main Results:

• The IL-4/IL-4Ralpha interaction involves a modular interface with three clusters.
• High-affinity binding of wild-type IL-4 relies on two clusters; mutating a third cluster enhances affinity.
• IL-13 uses similar binding determinants, indicating a shared modular interface architecture.

Conclusions:

• The modular interface allows independent generation of binding affinity and specificity.
• This mechanism explains how IL-4Ralpha achieves high specificity despite large differences in IL-4 and IL-13 binding affinities.
• Understanding these principles is essential for receptor-ligand interactions in growth factor families.